LGD-4033
LGD-4033 (now known as VK5211) is an investigational selective androgen receptor modulator (SARM) for treatment of conditions such as muscle wasting and osteoporosis, discovered by Ligand Pharmaceuticals and currently under development by Viking Therapeutics.
References
This page contains text from Wikipedia, the Free Encyclopedia - https://wn.com/LGD-4033
Podcasts:
PLAYLIST TIME: